NCT01425996 - A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 27, 2011

Primary Completion Date

October 3, 2014

Study Completion Date

October 3, 2014

Conditions

Carcinoma, Hepatocellular

Interventions

DRUG

Lipotecan® (TLC388)

"* Cohort A1: TLC388 15 mg/m2 x 6 dose + 3DCRT~* Cohort A2: TLC388 30 mg/m2 x 6 dose + 3DCRT~* Cohort A3: TLC388 40 mg/m2 x 6 dose + 3DCRT~* Cohort A4: TLC388 50 mg/m2 x 6 dose + 3DCRT (dose-escalation)~* Cohort Ax: TLC388 MTD x 6 dose + 3DCRT"

Trial Locations (2)

Unknown

Mackay Memorial Hospital, Taipei

Taipei Veteran General Hospital, Taipei